<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="t0030">
 <label>Table 6</label>
 <caption>
  <p>LigPlot analysis for top three lead compounds along with the control against SARS-CoV-2 M
   <sup>pro</sup>.
  </p>
 </caption>
 <alt-text id="al0110">Table 6</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Compounds</th>
    <th>Name</th>
    <th>Hydrogen bonds</th>
    <th>Hydrophobic interactions</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Cmpd35</td>
    <td>Bonducellpin D</td>
    <td>O2…..O(Glu166) (2.83 Å)
     <break/>O2…..N(Glu166) (2.91 Å)
     <break/>O4…..O(Glu166) (2.61 Å)
     <break/>O6…..N(Thr190) (2.92 Å)
    </td>
    <td>Met49, His164, Met165, Pro168, Asp187, Arg188, Gln189 and Gln192 (
     <italic>N</italic> = 8)
    </td>
   </tr>
   <tr>
    <td>Cmpd6</td>
    <td>5,7-dimethoxyflavaN-4′-O-β-d-glucopyranoside</td>
    <td>O8…..O(Glu166) (2.76 Å)
     <break/>O1…..N(Glu166) (3.22 Å)
     <break/>O7…..N(Thr190) (3.03 Å)
     <break/>O7…..N(Thr190) (2.44 Å)
     <break/>O9…..O(Gln192) (2.91 Å)
    </td>
    <td>Phe140, Leu141, Asn142, Gly143 Ser144, Cys145, His164, Met165, Leu167, Pro168, His172, Arg188 and Gln189 (
     <italic>N</italic> = 13)
    </td>
   </tr>
   <tr>
    <td>Cmpd34</td>
    <td>Caesalmin B</td>
    <td>O2…..N(Glu166) (3.32 Å)
     <break/>O2…..O(Glu166) (2.46 Å)
     <break/>O6…..N(Thr190) (3.01 Å)
     <break/>O6…..NE2(Gln192) (2.87 Å)
    </td>
    <td>Met49, His41, Tyr54, Cys145, His164, Met165, Leu167, Asp187, Arg188 and Glu189 (N = 10)</td>
   </tr>
   <tr>
    <td>Control</td>
    <td>α-ketoamide 13b</td>
    <td>N23…..OD1(Asn142) (2.83 Å)
     <break/>O37…..SG(Cys145) (3.31 Å)
     <break/>O41…..N(Glu166) (3.12 Å)
     <break/>O40…..N(Glu166) (2.98 Å)
    </td>
    <td>Thr26, His41, Gly143, Phe140, Leu141, Ser144, His163, His164, Met165, Pro168, Asp187, Gln189, Thr190 and Gln192 (N = 14)</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
